Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population.
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
16
10
2019
revised:
11
12
2019
accepted:
16
12
2019
pubmed:
31
12
2019
medline:
27
3
2020
entrez:
30
12
2019
Statut:
ppublish
Résumé
To determine if disparities in quality of surgical care exist between Hispanics and non-Hispanics undergoing radical cystectomy for bladder cancer. An observational cohort study was conducted retrospectively on patients who underwent radical cystectomy for urothelial carcinoma of the bladder at our institution between January 2005 and July 2018. Data was collected on demographic, clinical, and pathological characteristics of patients, including self-reported ethnicity. Univariable and multivariable logistic or linear regression analyses were used to evaluate the association of ethnicity with receipt of neoadjuvant chemotherapy, utilization of laparoscopic surgery, number of lymph nodes removed, and continent urinary diversion. We identified 507 patients in our database out of which, 136 (27%) were Hispanic and 371 (73%) were non-Hispanic. Compared to non-Hispanics, Hispanics had a higher body mass index (26.9 kg/m Disparity exists in the delivery of continent urinary diversions for Hispanic patients undergoing radical cystectomy for bladder cancer. Further investigation is needed to determine the potential causes for this disparity in care delivered.
Identifiants
pubmed: 31883879
pii: S0090-4295(19)31119-7
doi: 10.1016/j.urology.2019.12.017
pmc: PMC7063861
mid: NIHMS1558246
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-71Subventions
Organisme : NCI NIH HHS
ID : K23 CA178204
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA054174
Pays : United States
Organisme : NIDCR NIH HHS
ID : R21 DE030603
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002647
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Am J Health Syst Pharm. 2005 Sep 15;62(18):1873-82
pubmed: 16141106
Cancer. 2012 Jul 1;118(13):3345-55
pubmed: 22072536
Surg Infect (Larchmt). 2012 Oct;13(5):312-6
pubmed: 23116188
Urol Oncol. 2018 May;36(5):237.e9-237.e17
pubmed: 29338913
Spine (Phila Pa 1976). 2013 May 15;38(11):927-35
pubmed: 23232216
J Clin Oncol. 2006 Feb 20;24(6):904-9
pubmed: 16484700
J Natl Cancer Inst. 2002 Mar 6;94(5):334-57
pubmed: 11880473
Bladder Cancer. 2018 Jan 20;4(1):113-120
pubmed: 29430511
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Am J Health Behav. 2007 Sep-Oct;31 Suppl 1:S19-26
pubmed: 17931132
Urology. 2011 Sep;78(3):544-9
pubmed: 21782222
Cancer. 2014 Apr 1;120(7):1018-25
pubmed: 24339051
World J Urol. 2012 Dec;30(6):807-14
pubmed: 22832587
Ann Intern Med. 2003 Oct 7;139(7):558-63
pubmed: 14530226
Int Braz J Urol. 2008 Nov-Dec;34(6):691-8; discussion 698
pubmed: 19111073
J Gen Intern Med. 2003 Feb;18(2):146-52
pubmed: 12542590
Am J Public Health. 2003 Oct;93(10):1713-9
pubmed: 14534227
Arch Intern Med. 1994 Apr 11;154(7):761-7
pubmed: 8147680
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Breast Cancer Res Treat. 2013 Jun;139(2):561-9
pubmed: 23690143
BMC Public Health. 2016 Sep 13;16:975
pubmed: 27624540
N Engl J Med. 2003 Aug 28;349(9):859-66
pubmed: 12944571
Urol Oncol. 2018 Jun;36(6):308.e1-308.e9
pubmed: 29566978
Chest. 2005 Nov;128(5):3440-6
pubmed: 16304297
Lancet. 2018 Jun 23;391(10139):2525-2536
pubmed: 29976469